These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6712863)

  • 1. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.
    Zabludowski JR; Zoccali C; Isles CG; Murray GD; Robertson JI; Inglis GC; Fraser R; Ball SG
    Br J Clin Pharmacol; 1984 Mar; 17(3):309-16. PubMed ID: 6712863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man.
    Zoccali C; Zabludowski JR; Isles CG; Murray GD; Inglis GC; Robertson JI; Fraser R; Ball SG
    Br J Clin Pharmacol; 1983 Sep; 16(3):305-11. PubMed ID: 6626423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man.
    Fagard R; Cattaert A; Lijnen P; Staessen J; Vanhees L; Moerman E; Amery A
    Clin Sci (Lond); 1984 Jan; 66(1):17-25. PubMed ID: 6690191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
    Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
    Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of ketanserin in conscious rabbits.
    Takata M; Zhang X; Sugimoto T; Ikeda K; Tomoda F; Mikawa M; Iida H; Mizumura Y
    Jpn Heart J; 1986 Jan; 27(1):95-106. PubMed ID: 2941601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin and alpha 1-adrenergic antagonism in humans.
    Zabludowski JR; Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S123-5. PubMed ID: 2412032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1987 Nov; 24(5):599-606. PubMed ID: 3325090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ketanserin on cardiovascular, sympatho-adrenal and endocrine systems during physical exercise in man.
    Defer G; Guezennec CY; Fraitag B; Lhoste F
    Fundam Clin Pharmacol; 1987; 1(2):135-43. PubMed ID: 3315914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ketanserin on peripheral vascular pressor mechanisms in essential hypertension.
    Elliott HL; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S62-6. PubMed ID: 2459518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    Acta Med Scand; 1988; 223(2):125-31. PubMed ID: 3279724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic mechanisms and blood pressure in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the serotonergic antagonist ketanserin.
    Stott DJ; Robertson JI; Ball SG
    J Hypertens Suppl; 1985 Dec; 3(3):S191-3. PubMed ID: 2856702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic effect of ketanserin in mild to moderate essential hypertension.
    Woittiez AJ; Wenting GJ; van den Meiracker AH; Ritsema van Eck HJ; Man in't Veld AJ; Zantvoort FA; Schalekamp MA
    Hypertension; 1986 Feb; 8(2):167-73. PubMed ID: 2935497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of ketanserin in hypertension.
    McGourty JC; Silas JH; Cowen KJ
    Br J Clin Pharmacol; 1985 Jul; 20(1):37-40. PubMed ID: 3161531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation.
    Dabiré H
    Therapie; 1991; 46(6):421-9. PubMed ID: 1819150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of chronic ketanserin therapy on blood pressure and certain humoral and metabolic factors in patients with mild to moderate primary essential hypertension].
    Knypl K; Wocial B; Berent H; Kuçzyńska K; Wasowska T; Brym E; Czerniewska E; Wacławek-Maczkowska J; Januszewicz W
    Pol Arch Med Wewn; 1993 Aug; 90(2):95-104. PubMed ID: 8247951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of alpha-adrenoceptor antagonism by the 5HT2 antagonist, ketanserin (R49945), in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Spence CD; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1984; 11(6):597-604. PubMed ID: 6152610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.